Medtronic plc
MDT
Rangering i aksjer
#183
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Aksjekurs
$94.70
Sist synkronisert: 2026-10-16
Markedsverdi
$121.14B
Endring (1 dag)
-1.36%
Endring (1 år)
-1.13%
Land
IE
Handel Medtronic plc (MDT)
Kategori
Healthcare
Driftsmargin for Medtronic plc (MDT)
Driftsmargin per May 2026 TTM: 17.86%
Ifølge Medtronic plc sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 17.86%. Ved slutten av 2024 hadde selskapet en driftsmargin på 15.89%.
Historikk for driftsmargin for Medtronic plc fra 2000 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2026 (TTM) | 17.86% | 0.56% |
| 2025 | 17.76% | 11.77% |
| 2024 | 15.89% | -9.51% |
| 2023 | 17.56% | -3.25% |
| 2022 | 18.15% | 21.89% |
| 2021 | 14.89% | -10.14% |
| 2020 | 16.57% | -19.21% |
| 2019 | 20.51% | -7.49% |
| 2018 | 22.17% | 22.35% |
| 2017 | 18.12% | -2.53% |
| 2016 | 18.59% | 0.00% |
| 2015 | 18.59% | -17.08% |
| 2014 | 22.42% | -15.49% |
| 2013 | 26.53% | -4.22% |
| 2012 | 27.70% | -1.04% |
| 2011 | 27.99% | -7.50% |
| 2010 | 30.26% | 27.52% |
| 2009 | 23.73% | -12.14% |
| 2008 | 27.01% | -11.15% |
| 2007 | 30.40% | -7.35% |
| 2006 | 32.81% | -4.20% |
| 2005 | 34.25% | -2.17% |
| 2004 | 35.01% | 1.13% |
| 2003 | 34.62% | 3.28% |
| 2002 | 33.52% | -0.92% |
| 2001 | 33.83% | 0.77% |
| 2000 | 33.57% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 17.03% | -99.05% |
US
|
|
| 22.03% | -98.77% |
US
|
|
| 21.46% | -98.80% |
US
|
|
| 0.00% | - |
DE
|
|
| 28.09% | -98.43% |
US
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.